Healthcarenews17 Apr, 2024Business
The nuclear medicine and radiopharmaceuticals market is projected to reach USD 9.4 billion by 2028, up from USD 5.5 billion in 2023, with a compound annual growth rate (CAGR) of 11.3% during the forecast period. This robust growth is driven by the rising incidence and prevalence of target diseases and the need for early diagnosis using nuclear medicine. However, hospital budget cuts and high equipment prices pose challenges for the adoption of nuclear medicine, potentially affecting the growth of the market.
Budget Direct Insurance
Ev99mobi Green
Physio Perfomance
Fxpro
Ko66
Bj38
U88t2 Com
Nhà Cái One88
Vinhomes Cam Lam
Cts